USFDA issues warning letter to Cipla's Goa facility; stock plunges 3%

The company remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations, it added.

from India Infoline News Service https://ift.tt/2VpoBm3